NCT01062763
The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension
See it on ClinicalTrials.gov ↗119 people
23.5%
76.5%
28 womenmiddle line = equal numbers91 men
- Phase
- PHASE3
- Paid for by
- Ib Abildgaard Jacobsen
- Finished
- 2012-05
- Health conditions
- Arterial Hypertension, Hypertension, Resistant to Conventional Therapy, Diabetes Mellitus
- Who could join
- Anyone
- Ages
- 18 Years – 75 Years
- Average age
- mean 63.4 years
- Age 65+
- 47.9%
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnancy or planned pregnancy”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“Psychiatric disease”
- No cancer
Women with current or past cancer were turned away.
“Malignant disease”
Study titles and rules are shown in their original English.